Metraipolis › archive › dc_416ca97651d9

Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration — Europe PMC PMID:42306550

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42306550
DOI
10.1039/d6sc00011h
License (as archived)
solo-consultazione
Archived
2026-10-31T18:57:07.861Z
SHA-256 of the archived text
60ce548254bd32fedc7a1aee4aa6f2e8d5c5ea73648db261dd0ee151902fe5b1
Stable URL of this page
https://metraipolis.com/documento/dc_416ca97651d9

How to cite

Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration — Europe PMC PMID:42306550 — Europe PMC (en), https://europepmc.org/article/MED/42306550 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_416ca97651d9 (Metraipolis archive dc_416ca97651d9, sha256 60ce548254bd32fedc7a1aee4aa6f2e8d5c5ea73648db261dd0ee151902fe5b1)
BibTeX
@misc{dc416ca97651d9,
  title = {Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration — Europe PMC PMID:42306550},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42306550},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_416ca97651d9; sha256 60ce548254bd32fedc7a1aee4aa6f2e8d5c5ea73648db261dd0ee151902fe5b1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42306550. Agents can read the archived copy with the MCP tool read_document.